Strong momentum in Project Nanoenzalutamide
Company Announcement Nanoform Finland Plc February 29, 2024 08:10 a.m. Finnish time / 07:10 a.m. Swedish time Strong momentum in Project Nanoenzalutamide Project Nanoenzalutamide sees strong momentum. The clinical results in the pilot study were very promising. Now we are preparing for the manufacture of nanoformed material for the registration batches and the EU/US pivotal studies that are planned to start during 2024. In parallel, Nanoform and the members of the ONConcept[® ]Consortium have initiated discussions with many potential partners around this exciting project. The